Evogene Ltd EVGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Evogene Reports Financial Results for the Third Quarter and First Nine Months of 2026, Highlighting Progress in Two Internal Development Programs
AgPlenus Announces Significant Progress in Its Fungicide Discovery Programs Targeting New Modes of Action, with Activity Against Resistant Septoria and Additional Fungal Pathogens
Evogene Schedules Third Quarter 2026 Financial Results Release
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Trading Information
- Previous Close Price
- $0.31
- Day Range
- $0.30–0.33
- 52-Week Range
- $0.26–1.23
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 18.05M
- Market Cap
- $4.30M
- Volume/Avg
- 62,775 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.44
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 52
- Website
- https://www.evogene.com
Valuation
Metric | EVGN |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.44 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | EVGN |
|---|---|
Quick Ratio | 3.43 |
Current Ratio | 3.57 |
Interest Coverage | −4.16 |
Quick Ratio
EVGN
Profitability
Metric | EVGN |
|---|---|
Return on Assets (Normalized) | −68.16% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −87.41% |
Return on Assets
EVGN
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|%vh>h# | LOCK|s>h#c | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|^l$fcp | LOCK|N>$! | $95B | |||
| Moderna Inc MRNA | LOCK|tQ$>H?t | LOCK|Wss | $79B | |||
| argenx SE ADR ARGX | LOCK|<D?jST | LOCK|yP | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|%fwRHc | LOCK|b&X | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|$h$h!!wb | LOCK|!!^$Q | $30B | |||
| Incyte Corp INCY | LOCK|R<Rjc% | LOCK|&#& | $23B | |||
| BioNTech SE ADR BNTX | LOCK|@b?@TP | LOCK|&J | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|fH>&<&% | LOCK|lY^% | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|^@n%fL | LOCK|<#! | $15B |